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ABSTRACT 
PROBIOTICS AS A TREATMENT FOR INCREASED NIGHTTIME ACTIVITY IN RHESUS 
MACAQUES (MACACA MULATTA) DISPLAYING SELF-INJURIOUS BEHAVIOR 
SEPTEMBER 2016 
LAUREN L. STANWICKS, B.S., UNIVERSITY OF MASSACHUSETTS 
M.S., UNIVERSITY OF MASSACHUSETTS 
Directed by: Professor Melinda A. Novak 
 
 Self-injurious behavior (SIB) is a behavioral pathology seen in a small 
percentage of humans and non-human primates.  In one previous study, macaques 
with SIB had more sleep disruption than controls, but observations were 
limited.   Two studies were conducted: a baseline study to investigate nighttime 
activity in rhesus macaques (Macaca mulatta) displaying SIB and controls, and a 
probiotic study to assess probiotic Bifidobacterium infantis 35624 for high nighttime 
activity.   Subjects were 13 rhesus macaques, 5 with SIB (3 females; 1 SIB).  
Videocapture of Nighttime Activity (VNRA) was developed to record in complete 
darkness.   IR-receptive webcams were connected to a laptop running 
ISPYCONNECT, software which recorded movement.    Subjects were observed 
during the entire lights-off period (8pm-7am).   Measures included total movement 
time (TMT), movement  in hour 1 (HR1) and hour 11 (HR11), and number of 
videos.   In the baseline, SIB subjects had higher TMT (p <.01), higher HR1 (p<.001), 
and generated more videos ≥10s (p <.01) and ≥30s (p < .01).   Effects persisted 
across probiotic treatment, with higher measures for SIB than control for TMT 
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(p=.01), HR1 (p<.01), HR11 (p=.05), ≥10s (p=.01), ≥30s (p=.01), with a trend 
towards significance in HR1 (p=.06).    Sleep disruption remained consistent 
indicating that Bifidobacterium infantis 35624 had no effect on sleep disruption, and 
also that increased nighttime activity seems to be a persistent characteristic of SIB 
subjects.  It is unknown if increased nighttime activity affects SIB subjects; it may 
result in elevated SIB, or the SIB pathology could result in sleep disruption. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Nighttime Activity and Sleep Measurements 
The purpose of this thesis was to examine nighttime activity in rhesus 
macaques (Macaca mulatta) displaying self-injurious behavior (SIB) and controls 
during probiotic treatment.  SIB is a behavioral pathology seen in a small percentage 
of both humans and non-human primates that presents as self-wounding and in 
milder cases, self-directed biting (Novak 2003).  Sleep disruption has been noted in 
SIB subjects compared to controls (in macaques: Davenport et al. 2008, in humans 
with developmental disabilities: Symons et al. 2000, Brylewski et al.1999). The goal 
of this thesis was to determine if sleep disruption was present in SIB monkeys with 
a mild biting pathology prior to probiotic treatment, and whether probiotic 
treatment could ameliorate these sleep disturbances and SIB.  Numerous studies in 
rodents confirm that probiotic supplements both reduce anxiety and abnormal 
behavior (Dinan et al. 2013, Lutgendorff et al. 2008, Desbonnet et al. 2010, 
Crumeyrolle-Arias et al. 2014, Sudo et al. 2004).   
Rhesus macaques are an excellent animal model for human nighttime 
behavior; macaques are diurnal and have a close phylogenetic relationship to 
humans (Hsieh et al.  2008). With minor exceptions, their sleep habits and sleep-
wake architecture mimics that of humans (Hsieh et al. 2008).  Most sleep studies 
performed on rhesus macaques record electroencephalograms (EEGs) or telemeters 
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that require either surgically implanting a cap onto the subject's scalp or using 
actigraphy devices implemented in permanent collars around the neck (Papailiou, 
Sullivan, & Cameron 2008). These procedures are initially stressful, may have long-
term impact on nighttime activity, and would be particularly difficult to implement 
in monkeys with SIB.  In this thesis, I evaluated a completely non-invasive method of 
nighttime movement scoring without the need for surgical procedures or collars. 
The method involved motion activated video (Videocapture of Nighttime Activity; 
VRNA).  While VRNA is not a measure of sleep per say; rather, it provides an 
estimate of sleep by assuming periods of low activity represent sleep. Thus VRNA 
provided a general measure of activity (in terms of the total length of videos 
generated), # of significant awakenings (videos of 30 s or longer), and most 
importantly, allowed for the identification of specific activities (in terms of scoring 
the videos).   
In humans, sleep is typically studied using polysomnography (PSG). It 
includes EEG, electrooculography, and electromyography recordings in order to 
determine sleep stages via brain waves and muscle movements.  When PSG is 
impossible or impractical to use, actigraphy can be employed to measure nighttime 
activity. Actigraphy is a non-invasive method of monitoring rest and activity cycles 
by measuring gross motor activity via a unit worn on the subject (Sadeh & Acebo, 
2002). Polysomnography is considered the gold standard measure of sleep, whereas 
actigraphy is a one-dimensional measure that provides an estimate of sleep by 
measuring movement (Ancoli-Israel et al. 2003). Actigraphy has its limitations in 
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that it cannot determine sleep stages, and there is no way to discriminate between a 
subject being asleep or awake but motionless. High correlations between actigraphy 
and PSG have been shown under lab conditions, and one can assume if the subject is 
not moving they are asleep (De Souza et al. 2003, Ancoli-Israel et al. 2003, & Marino 
et al. 2013).   
EEG can be extremely difficult to employ in non-human primate subjects 
because of the tendency for the subject to try to remove the device. Telemetry 
records sleep electrocorticogram directly from the brain in non-human primates, 
and is an extremely accurate measure of sleep, however it is very invasive and 
involves surgical placement (Crofts et al. 2001). Although actigraphy has been used 
in macaques, it requires placing a permanent metal collar on their necks or 
attaching the device between their shoulder blades to which some animals adapt 
poorly (Golub & Hogrefe 2015, Barrett et al. 2009, Papailiou, Sullivan, & Cameron 
2008).  Subcutaneous implants are also possible and provide “less restraint” than 
collars but monkeys have been known to “pick” at the implant with a possible risk of 
infection (Darbin et al. 2009).  Although the technique used in this thesis was a 
measure of movement, as is actigraphy, it was not identical to actigraphy.  
Actigraphy provides a record of movement but it does not reveal what the subject 
was doing during specific movements.  While there are algorithms that can 
determine the nature of movement during actigraphy recording, in contrast, VRNA 
has the advantage of providing a visual record of all movements which can then be 
scored for the frequency and duration of various behavioral categories.   
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 Video recording methods to assess nighttime activity are comparable to 
actigraphy, however it can pose some challenges of its own that actigraphic methods 
do not involve.  A 1998 study compared conventional EEG analysis to the video 
scoring of sleep and wakefulness using 5-minute scan sampling on VHS tapes in 
rhesus macaques (Balzamo et al. 1998).  The two scoring methods (EEG and 
behavioral assessments) were significantly related (r=.9996), showing that video 
methodology is relevant as a non-invasive technique complementary to 
conventional EEG analysis for sleep studies in rhesus macaques (Balzamo et al. 
1998). Video scoring techniques have only become more precise since then: the 
speed of video recording in this thesis is no less than 30 frames/s compared to the 1 
frame/s in the 1998 paper, allowing for more accurate recording. Additionally, 
video scoring in this thesis is done via computer program for the entire nighttime 
period, creating a wider range of sleep time to assess and negating any human error 
during scoring that the 1998 technique may have encountered. However, the 
macaques in the 1998 paper were housed in small specialized spaces, where it was 
much easier to observe the animals at a short distance in order to gain sleep stage 
(NREM vs REM) information.  Today, regulations require larger housing spaces for 
non-human primates, thus up-close observations of sleep are largely impossible to 
obtain at a facility such as the one in this thesis where subjects had spacious 
housing. At the distance needed to capture the whole cage and the range of motion 
afforded to the subjects, it would have been impossible to differentiate sleep from 
sitting quietly with the eyes open or closed. In this thesis, the video measure 
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assessed nighttime activity. However, there are many relevant parallels, noted 
above, that exist between activity measures and more invasive measures of sleep.  
 
1.2 Self-Injurious Behavior  
 Self-injurious behavior is a behavioral pathology that has been observed in 
both humans and nonhuman primates.  In rhesus macaques it presents as self-biting 
that can lead to wounds requiring veterinary care, and occurs in 5-13% of captive 
individually housed non-human primates (Novak 2003).  Nonsuicidal self-injurious 
behavior occurs in the general human population with commonalities between 
macaques and humans across prevalence, etiology, triggering events, function, and 
therapeutic intervention (Novak et al. 2014).   
The cause of SIB is not well known.  Associations can be made between SIB, 
restrictive environments, and atypical rearing conditions (Bellanca & Crockett 2002, 
& Lutz et al. 2003).  Early life events such as rearing condition seem to have an effect 
on SIB status; nursery reared macaques are more likely to develop SIB than their 
mother-reared counterparts (Lutz et al. 2004, Gottlieb et al. 2013).  Additionally, 
certain gene polymorphisms of the tryptophan-hydroxylase receptor 2 gene (TPH2) 
(Chen et al, 2010) appear to confer increased vulnerability to SIB regardless of early 
rearing environments.  The SIB phenotype has also been associated with a 
dysregulation of the stress response system manifested as lowered hypothalamic-
pituitary-adrenal (HPA) axis activity in response to an acute stressor (Tiefenbacher 
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et al. 2000; Tiefenbacher et al. 2004) and elevated HPA axis activity in response to 
chronic stress conditions as compared to controls (Davenport et al., 2008). 
 Emerging evidence suggests that individuals with SIB also show disturbed 
sleep patterns. In humans, sleep disturbance can take different forms: delayed sleep 
onset, impaired sleep maintenance due to many nighttime awakenings, or early-
morning awakening (American Psychiatric Association 2000).  It can also be 
characterized as onset or maintenance insomnia: difficulty falling asleep or the 
inability to stay asleep, respectively (Morin et al. 2007). In humans, subjects who 
exhibit SIB sleep less than controls (Symons et al. 2000; Brylewski et al. 1999).  Such 
individuals show reduced sleep time, delayed sleep onset, and multiple nighttime 
awakenings (Symons et al. 2000, Chaney et al. 1994).  In the only study to date on 
sleep disruption in SIB macaques, they were more active at night than controls 
(Davenport et al. 2008).  However, the data collection was labor intensive involving 
continuous scoring of six hour long videotapes which did not span the entire 
nighttime period and included manual scoring which left room for human error.    
 Dysregulation of the HPA axis has been identified as a defining feature of SIB 
(Tiefenbacher et al. 2000; Tiefenbacher et al. 2004, Davenport et al., 2008). In 
humans, the HPA axis has a large role in controlling alertness and sleep, and HPA 
axis dysfunction can cause sleep disruption (Buckley & Schatazberg, 2005).  Sleep 
initiation is associated with low HPA axis activity; furthermore, sleep seems to 
suppress the HPA axis (Buckley & Schatazberg, 2005).  Conversely, sleep 
deprivation has been associated with HPA axis activation and these interactions are 
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consistent with the finding that early morning salivary cortisol concentrations are 
negatively correlated with sleep quality, subjective estimation of sleep quality, and a 
decreased feeling of recovery after awakening (Buckley & Schatazberg, 2005 & 
Backhaus et al. 2003).  Sleep disruption seems to impact abnormal daytime 
behaviors as well: nocturnal sleep time is negatively correlated with alertness in 
insomnia; and individuals with sleep problems displayed more daytime irritability, 
stereotypy, and hyperactivity (Brylewski et al., 1999). It is likely that the HPA axis 
disruption seen in SIB subjects could be linked to sleep disruption.  
 Despite efforts of many researchers, a universally effective treatment for SIB 
is yet to be developed. Cognitive Behavioral Therapy (in humans; Saunders et al., 
1996) and medication (humans and non-human primates) such as serotonin 
reuptake inhibitors (e.g. ., fluoxetine in rhesus macaques; Fontenot et al., 2009, and 
venlafaxine in humans; Carmianti et al., 2006), alpha2A receptor agonists 
(guanfacine in rhesus macaques; Freeman et al., 2015), allosteric modulators of 
GABAA receptors (diazepam in rhesus macaques; Tiefenbacher et al., 2005), and 
opioid antagonists (naltrexone in rhesus macaques; Kempf et al., 2012, and humans; 
Benjamin et al., 1995) are often utilized. However therapy is not always successful, 
and there is no medication specifically designed to treat SIB. Some medications that 
may help some human subjects produce severe side effects in others (Janowsky et 
al., 2005;  Mahatmya, Zobel, & Valdovinos 2008). A similar biphasic response was 
observed in rhesus monkeys treated with diazepam: some monkeys improved but 
others showed an increase in biting and wounding (Tiefenbacher et al., 2005).  
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Medications often used to alleviate symptoms of this pathology have varying 
degrees of effectiveness across individual subjects. Antidepressants have an effect 
on the condition, but only for some subjects and opioid antagonists are similar in 
that they can help but will sometimes will make symptoms worse for some 
individuals (Mahatmya, Zobel, & Valdovinos 2008).  It is also not ideal to give 
medication that has large effects on behavior to non-human primate subjects that 
may be under research protocols where this medication could adversely affect the 
results of the study. 
 
1.3 Nonpharmacological Treatment for SIB: Probiotics 
Probiotics, which are typically used to boost gastrointestinal health, have 
been recently shown to have effects that extend beyond typical improvements in 
digestion.  Probiotics are microorganisms that colonize the body and affect the host 
beneficially. They are not just one organism but can be many different organisms 
that may live in many different habitats all over the body (Schrenzemeier & De 
Vrese 2001).  Habitat preferences for specific strains can differ between species; 
different strains of probiotic bacteria may colonize different places and can exert 
different effects based on their choice of habitat, even in a single subject (Freter 
1992, Schrenzemeier & De Vrese 2001).  Probiotics work by altering the 
microbiome, which is made up of all of the microbes and their genes that are present 
in a subject.  It has been shown that when the collective population structure of the 
microbiome is changed, human health changes (Baquero 2012).  The microbes in 
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the microbiome are living things  which may receive signals the body sends, such as 
stress signals, and via various mechanisms (neural, immune, or endocrine) can 
change brain chemistry based on these signals. These changes can be behavioral or 
molecular modifications such as of HPA axis activity, gene expression, or 
neurotransmitters like noradrenaline, 5-HT, and GABA (Parashar & Udayabanu 
2015, Galland 2014, Lutgendorff et al. 2008). One of the aims of this thesis was to 
see if altering the intestinal microbiome by probiotics has an effect on nighttime 
activity in SIB and control subjects.  In this thesis, subjects received the probiotic 
Bifidobacterium infantis 35624 (commercially manufactured as ALIGN).  
Bifidobacterium infantis 35624 has been shown to colonize the gut through 
continuous oral supplementation (Charbonneau et al. 2013).  The specific strain 
used in this thesis can not only improve gastrointestinal health and help with 
symptoms of gastrointestinal problems but also may modulate inflammation 
beyond the gut, help with pain control, improve symptoms of depression, modulate 
effects on stress, and affect immunoregulation (Desbonnet et al. 2008, Lomasney et 
al. 2013, Groeger et al. 2013, Mckernan et al. 2010, Konieczna et al. 2012).  
Bifidobacterium has been labeled a psychobiotic, a live organism that in proper 
amount produces psychiatric health benefits; these benefits come from the ability of 
some probiotics to produce neuroactive substances that can affect the brain (Dinan 
et al. 2013).  In Bifidobacterium infantis 35624 it is believed these effects come from 
an ability of B. infantis to possibly normalize HPA axis activity (Dinan et al. 2013, 
Lutgendorff et al. 2008).  In a 2010 study that looked at the effects of 
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Bifidobacterium infantis 35624 in a model of depression, administration was shown 
to normalize immune responses, reverse behavioral deficits, and restore 
noradrenaline in the brain (Desbonnet et al. 2010).  Studies have also shown that 
germ-free mice, or mice without microbiomes, have higher HPA responses to acute 
stress. However, administration of Bifidobacterium infantis normalized the 
exaggerated HPA activity in these mice thus modulating HPA effects (Crumeyrolle-
Arias et al. 2014, Sudo et al. 2004).   
There is only one published study that examines the possible direct 
relationship between probiotics and sleep quality: administration of the probiotic 
Streptococcus, a lactic acid bacteria similar to Bifidobacterium, improved sleep 
quality in humans (Jackson et al. 2015).  Probiotics may affect nighttime behavior 
through melatonin; probiotic treatment  increases levels of morning melatonin 
(Wong et al. 2014).  Melatonin is secreted at night by all species and exogenous 
melatonin has sleepiness-inducing effects that can shift the phase of the human 
circadian clock (Ardent & Skene 2005).  Melatonin can be synthesized the in the 
gastrointestinal tract and may even alter the gut flora (Konturek et al. 2011, Schultz 
et. al. 2006).  If probiotics helped increase melatonin levels, as shown before in 
irritable bowel syndrome patients, they may possibly have had visible effect on 
nighttime activity as well (Wong et al. 2014). 
 
1.4 Objective of Current Thesis 
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The objective of this thesis was to examine effects of nighttime behavior in 
SIB and control subjects undergoing probiotic treatment.  This involved two studies: 
a baseline study to establish baseline nighttime activity levels in the subjects, and a 
probiotic study to test the effectiveness of  Bifidobacterium infantis 35624 in 
alleviating sleep disruption.  In the baseline study, the hypothesis to be examined 
was that SIB was associated with sleep disruptions.  This was assessed through 
nighttime activity data measures collected by the VRNA system including total 
nighttime movement time, video lengths, and total time between videos.  Two 
predictions followed from this hypothesis.  Prediction 1:  For the baseline data 
collection, rhesus macaques exhibiting the SIB phenotype would be more active 
during the night based on previous findings in humans and macaques (for 
macaques, Davenport et al. 2008, for humans, Polk & Liss 2007, Symons et al. 2000, 
Brylewski et al. 1999).  Prediction 2: Rhesus macaques that had increased nighttime 
activity would also exhibit more locomotor behaviors and total behaviors the 
following morning. This prediction was based on findings in human insomniacs that 
nocturnal sleep time is negatively correlated with alertness; also, individuals with 
sleep problems have been seen to have more daytime stereotypy and hyperactivity 
(Stepanski et al. 1988, Brylewski et al., 1999).   
For the treatment study, the hypothesis was that probiotic treatment would 
improve sleep, which was assessed through the same VRNA system and nighttime 
activity measures as the first study. In previous studies with humans and rats, 
probiotic supplementation increased sleep times, increased melatonin levels, and 
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attenuated HPA axis activity in response to stress, (Jackson et al. 2015, Wong et al. 
2014, Crumeyrolle-Arias et al. 2014, Sudo et al. 2004).  
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CHAPTER 2 
ESTABLISHMENT OF METHODOLOGY (VRNA) AND BASELINE EXPERIMENT 
2.1 Introduction 
The goal of this experiment was to examine the nighttime behavior of SIB 
and control subjects prior to probiotic treatment.  More specifically, the aim was to 
determine whether macaques with a mild form of SIB (biting rather than wounding) 
show sleep disturbances that have been reported for macaques with more serious 
forms of SIB.  Assessment of nighttime activity was accomplished using the VRNA 
system.  The VRNA system, which comprised an IR (infrared) light, IR receptive 
webcams, a laptop, and the motion sensing program ISPYCONNECT, also had to be 
tested and established as a reliable way to collect nighttime behavior data. 
In this baseline study, we predicted that subjects exhibiting SIB phenotype 
(SIB) would be more active at night than controls as measured by 1) the total time 
of movement, 2) the number of videos that were less than 10 secs and exceeded 
both 10 secs and 30 secs, and 3) longest period with no movement during the night.  
We also predicted that subjects with SIB would take longer to get to sleep (longer 
TBstart measure and Hour 1 Time) and wake up earlier (longer Hour 1 Time). 
Daily morning behavior was also collected with the objective of assessing 
possible relationships between nighttime activity and daytime behavior.  Sleeping 
less than others and moving more at night have been associated with behavioral 
difficulties in human children such as anxiety and depression; human subjects with 
sleep problems display more daytime irritability, stereotypy, and hyperactivity 
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(Goodnight et al. 2007, Gregory et al. 2008, Brylewski et al., 1999).  Humans with 
insomnia also sleep less than controls but are significantly more alert than controls 
the following day (Stepanski et al. 1988).  Similarly, we predicted that amount of 
nighttime activity (reduced sleep) would be positively correlated with behavioral 
activity the next day. We also examined nighttime activity the day after behavior, 
and predicted high daytime activity would be positively correlated with high 
nighttime activity that night. 
 
2.2 Methods 
2.2.1 Subjects 
The subjects of this study were 13 rhesus macaques (10 males) maintained 
at the University of Massachusetts Amherst Primate Laboratory.  Six of the subjects 
had a mild self-directed biting pathology and one of those was a female.  SIB status 
of subjects was established through extensive 5 min observations of the monkeys 
both in the am and pm (~150 samples per monkey) and from reports of biting 
behavior during basic husbandry procedures. Those subjects which displayed any 
self-directed biting were placed into the SIB group. Biting behavior was relatively 
rare during these observations ranging from 0.02 – 0.61 averaged across all 
observations for each subject. All the macaques were adults, the average age of the 
subjects being 14 years with a range of 11 to 25 years.  All subjects were housed 
indoors in either Allentown cages (5 x 6 x 2 ft.) or floor-to-ceiling pens (4 x 6 x 8 ft.).  
Four of the subjects were housed in grooming contact pens.  The remaining 9 
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subjects were housed in individual cages within colony rooms where they could 
interact with other monkeys at a safe distance.  The macaques were kept in five 
different colony rooms with two to four individuals per room.  All but one room 
contained at least one SIB and one control subject. The light cycle the macaques 
were exposed to was an automated 13 light/11 dark cycle where the lights in all 
macaque rooms were off from 8pm to 7am every night.   
 
2.2.2. Equipment  
The equipment used in this study consisted of:  1) two 850nm infrared (IR) 
lights (Super Circuits model IR34), 2) four modified Logitech C920 webcams, 3) two 
Dell Inspiron 3000 receiving laptops connected to the modified Logitech C290 
webcams , and 4) the motion sensing and recording program ISPYCONNECT.  The 
Logitech C920 webcams were consumer-grade high end webcams that were 
modified by removing the IR filter that was behind the lens and reassembling them, 
recorded at 30 frames per second and produced a 1080 pixel picture.  The reason 
for this modification was to ensure that the webcams  could respond to them  IR 
light.  IR light is not visible to humans or rhesus macaques so the recording occurred 
in complete darkness (Jacobs 1996).  IR light is also safe for both humans and non-
human primates.  Infrared light 550 nm or greater is not at all hazardous, so 
exposure at 850 nm such as the kind in this study should not have posed any retinal 
hazard to the subjects (Sliney & Mellerio 2013).   
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2.2.3 ISPYCONNECT Program Setup 
The program used for motion recording, ISPYCONNECT, required 
configuration before recording could begin.  ISPYCONNECT is open source software 
initially developed as ghost hunting software. The software had many different 
features including scheduling of recording, multiple movement threshold levels, 
inactivity recording after movement recording, minimum recording times, and 
recording on movement detection or lack of movement detection.   
For this study, the program was configured so that it started recording after 
any motion detection, and would record for 5s after motion stopped.  A permanent 
schedule was applied so the cameras would automatically turn on during the lights-
off period in the colony rooms (8pm - 7am).  The automatic start of the cameras at 
the proper time allowed them to be set up hours in advance so that the monkeys’ 
activity just prior to sleep was not disrupted.   
The trigger threshold value for movement was set at 0.001, the lowest 
possible value.  The trigger threshold was part of the motion detection code of the 
program which counted the number of pixels in a single frame that change color 
(indicating movement) from one frame to the next.  If the number of changed pixels 
exceeded the trigger as a percentage of the total pixels, the camera was turned on.  
So setting the trigger to .001 was a setting a pixel trigger to .001%.  If 1/100,000 of 
the total image in the frame changed color (detected movement) before the next 
frame, then the camera was triggered to start recording.  The pixel resolution of the 
videos created was 1080 pixels, so this would be 0.01 of a pixel difference to trigger 
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recording. The cameras used in this thesis recorded at 30 frames per second. thus 
the slowest the camera would have been turned on .03s after a movement had been 
detected.   
 
2.2.4 Procedure 
In the late afternoon of evening collection, the light and camera were placed 
inside the colony room facing in the direction of the subject as close as possible 
while insuring their whole cage was in view.  The camera was attached to a laptop 
on the outside the colony room door.  The program (ISPYCONNECT) was running on 
the computer at all times and was set to record motion data for 11 hours on the 
same recording schedule as the light cycle (8pm-7am).  The equipment was 
removed from the rooms the next morning between 8-8:30 am either by M.  Novak 
or by animal care staff.   
 
2.2.5 Daily Behavior Scoring 
 All subjects underwent two behavioral assessments daily (AM: 9-10 and PM: 
4-5) that were each five minutes in length.  The Behavioral Profile Scoring System 
recorded the presence/absence of 32 categories of behavior in twenty – 15-second 
bins for a total of 5 minutes generating modified frequency scores that ranged from 
0 (never observed) to 20 (observed in every 15-second interval).  Daily behavior 
was compiled into two global categories: 1) : total number of behaviors and 2) total 
number of locomotor behaviors (active stereotypy such as pace, and locomotion) 
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recorded during the observation period. Data were analyzed to determine if daytime 
activity predicted nighttime activity, or if nighttime activity predicted the next day’s 
daytime activity.   
 
2.2.6 Data Collection 
  Over three months, six baseline trials were collected on each subject.  A trial 
represented an entire nighttime period of activity from 8pm-7am. The long 
preliminary trial time was due to a learning curve with the appropriate recording 
angles, apparatus, and software. After a night of recording, ISPYCONNECT generated 
a list of videos that represented every instance of movement. The videos were then 
manually compiled into one merged video which showed every movement the 
subject had made during a single night.  The program recorded movement data 
automatically; the only manual data manipulation needed was the merging of the 
individual movement videos so there was little human error in data coding.   
The video recording program provided several measures. To assess the 
duration  of all movements during the night, the measure of the total time spent 
moving (TMT) was used. To examine how quickly the monkeys settled down, total 
movement during the first hour after light offset was examined (Hour1Video). To 
determine whether monkeys with SIB awoke earlier than controls, the total 
duration of the videos c created in the last hour before the lights turn on 
(Hour11Video) was used.. To investigate a measure of more sustained movement, 
the number of videos created over 10 seconds long (≥10sVids) was used. To 
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examine the movements longest in duration, and therefore those where the subject 
was most likely to be awake, the number of videos created over 30 seconds long 
(≥30sVids) was calculated.  The number of videos less than 10s long (<10sVids) was 
used to assess the shortest movements a subject could make, those that may just be 
a brief shift of position during the night. Other measures collected were the length of 
the longest time between videos (TBvid) and the start time of this period (TBstart). 
This measure revealed the longest period of sleep and the time in which it started. 
IT CAN’T BE LATENCY. The data were expressed in seconds when appropriate with 
video durations rounded to the nearest hundredth second.  These measures 
effectively examined the three types of sleep disturbance identified by the American 
Psychiatric Association: delayed sleep onset (Hour 1 Video, TBstart), impaired sleep 
maintenance due to many nighttime awakenings (TMT, <10s Vids, ≥10s Vids, 
≥30sVids, TBvid), or early-morning awakening (Hour 11 Video) (American 
Psychiatric Association 2000). 
 
2.2.7 Data Analysis 
Nighttime activity was analyzed using Analysis of Variance (ANOVA) with SIB 
status as the between subjects variable and trial as the within subjects variable.  The 
following variables were analyzed: TMT, <10sVids, ≥10sVids, ≥30sVids, 
Hour1Video, Hour 11 Video, TBvid, and TBstart. 
Daytime behavior was compared to nighttime activity using Pearson 
correlations with a Bonferroni correction for each individual trial. Morning 
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behaviors were grouped into locomotor score (locomotion, crooktail, and 
movement stereotypies) and total number of behaviors a subject displayed in a 
sampling period.  Correlations between morning behaviors and TMT, Hour 11 Video, 
and Hour 1 Video were examined to determine if nighttime movement correlated 
with morning behaviors.   
 
2.3 Results 
2.3.1 Feasibility of Videocapture of Nighttime Activity 
Feasibility of VRNA was assessed to assure that the method provided an 
accurate representation of the nighttime movements a subject displayed.  Good 
quality images were produced by the webcams capturing the illumination of the IR 
light on the subjects (See Figure 2.1). Observation of all of the videos occurred the 
morning after every recording as the data were compiled to ensure sufficient video 
capture and to check for any movement that was not produced by the subject.   
Short Video Assessments: One aspect of feasibility was to determine whether 
subject movements actually occurred during very short videos.  To assess feasibility, 
a group of four observers watched randomly chosen 6-7 second videos to determine 
whether movements were detectable.   There was 100% agreement that movements 
occurred in the observed videos. These movements usually involved shifts of head 
or body position.  Thus, the program likely does not pick up very small movements 
of individual fingers or eyes, but can readily detect clear body shifts or head 
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movements. 
 
Figure 2.1 Examples of video stills taken with the VRNA system. A) One 
singly housed female in an Allentown cage looking. B) One pen-housed male 
stretching  
 
2.3.2 Description of Sleep Patterns 
Three sleep postures were identified: 1) sitting upright, (including sitting in 
hammocks), 2) lateral recumbency, or 3) prone.  Supine positions were not 
observed for any subject.  As noted in Table 2.1, the most common sleep position 
was sitting upright (shown by all the subjects). The next most common pattern was 
lateral recumbency (shown by 12 of the subjects). The least common pattern was 
sleeping in a prone position (shown by 6 of the subjects).  In terms of variation in 
sleep pattern, 6 subjects used all 3 sleeping positions during the night, 5 subjects 
used 2 sleeping positions, whereas 2 subjects spent the night sleeping in a sitting 
position.    Subjects preferred the uppermost parts of cages for sleep, very rarely 
sleeping on the bottom cage floor and never sleeping on shavings.  No left/right cage 
position seemed to take precedence for most subjects, however four (two pen 
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housed, two Allentown housed) invariably chose same side (See Table 2.2).  Only 
prone position was observed in the pen housed animals.  
 When ran as an ANOVA with caging type as the between subjects variable, 
no differences in nighttime activity patterns were found. However, subjects in 
Allentown cages versus pen cages had different sleeping place preferences.  
Allentown cages have two large parallel metal bars to use as perches, and wire mesh 
floors. Pen subjects have PVC pipes bound together to use as perches, floors covered 
with shavings, and some have hammocks which for these purposes were considered 
perches.  More subjects in pens preferred to sleep on perches. Three Allentown-
housed subjects varied their sleeping place between the perches and floors, three 
out of the six Allentown subjects slept exclusively on perches. Very little locomotion 
or feeding behavior occurred during the nighttime period, with most movements 
being scratches or simple shifts of position.  Of those subjects in pens, four out of the 
six had hammocks but only two preferred to sleep in them.  
Subject Sitting Lateral 
Recumbency  
Prone Total Positions 
Recorded 
V38 Y Y N 2 
V42 Y Y N 2 
N02 Y N N 1 
V43 Y Y Y 3 
V27 Y Y  N 2 
P58 Y Y Y 3 
RQ789 Y Y N 2 
RQ705 Y N N 1 
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Table 2.1 Sleeping postures observed in baseline trials by subject and sex. All 
subjects who displayed prone sleeping positions also displayed lateral recumbency 
 
 
 
Cage Style Subject Right 
Side  
Left 
Side 
Both 
Sides 
Hammock  
(if available;  
4 subjects) 
Exclusively 
perches  
Bottom 
Half of 
Cage 
Pen V38 Y Y    Y N/A Y N 
V42 Y Y Y Y N N 
V43 Y Y Y Y N N 
V27 Y Y Y N/A Y N 
ZA63 Y Y Y N Y N 
ZA63 Y Y Y 3 
ZA54 Y Y Y 3 
I18 Y Y N 2 
ZA02 Y Y Y 3 
N01 Y Y Y 3 
Total  13 
(all)  
14 6 n/a 
  
24 
 
ZA54 Y Y Y N Y N 
Total 
Pen  
6 6 
(all) 
6 2 4 0 
Allentown RQ789 Y Y Y N/A N N 
RQ705 Y Y Y N/A Y N 
N02 Y N N N/A Y N 
P58 Y Y Y N/A N Y 
I18 N Y N N/A N N 
ZA02 Y Y Y N/A Y N 
N01 Y Y Y N/A N N 
Total 
Allento
wn 
6 6 5 N/A 3 1 
All 
Subjects 
Total  12 12 11 2 7 0 
Table 2.2 Sleeping place preference of subjects based on subject and cage type.    
Right and left sides of pen cages were determined by the viewpoint of the nighttime 
video.   Pen-housed subjects seem to prefer perches to other options of sleeping in 
hammocks or directly on shavings.   Subjects in Allentown cages have the choice of a 
perch or metal floor.    
 
2.3.3 Nighttime Activity Differences Between SIB and Control Subjects  
As predicted and as noted in Fig. 2.2, SIB subjects showed increased 
nighttime activity, generating a TMT mean nearly twice that of the controls 
(1752.06s ± 209.25 SEM vs. 845.05s ± 193.73 SEM, respectively; F(1,11)=10.12.  
p<.01). There was also a significant effect of trials for TMT, but the effect was not 
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systematic, neither decreasing nor increasing across trials (F(5,55)=2.50 p=.04). 
 
Figure 2.2 Difference between SIB and control subjects for average 
nighttime movement time over the baseline phase (p< .01).  
 
There was no difference in the <10s videos measure (SIB mean 153.03 ± 
33.80 SEM vs. Control 115.93 ± 31.30 SEM; F(1,11)=1.83, p=0.20), indicating no 
variability between groups on the shortest videos the subjects created. However, as 
noted in Fig. 2.3, SIB subjects generated significantly more videos ≥10s than control 
subjects (96.19 videos ± 10.57 SEM vs. 45.64 videos ± 9.79 SEM respectively; 
F(1,11)=12.32, p<.01).  Number of videos ≥10 seconds also varied significantly across 
trials (F(5,55)=2.69, p=.03), and there was an interaction between SIB and trial as well 
(F(5,55)=2.71, p=.03) that was not systematic.  Greater than 30s Videos was an open-
ended measure including all videos created over 30s, these ranged from 31s to 7 
min however almost all were between 30s and 1 min. The number of  ≥30sVids 
generated  varied by SIB status (See Fig.  2.3; F(1,11)=10.01, p<0.01), with the SIB 
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subjects showing nearly four times the number of long bouts of activity compared to 
the controls (11.86 ± 2.07 SEM vs.  2.95 videos ± 1.91 SEM respectively.  
 
Figure 2.3 Average number of videos above 10s and 30s per night for SIB and 
control subjects during the baseline phase, both (p<.01)  
 
 
The final measure that yielded significance was Hour1Video (See Fig. 2.4); 
there was a significant SIB effect (F(1,11)=18.04, p=0.001) with an mean of 616.72s ± 
48.69 SEM of video created in the first hour (8pm-9pm) by SIB subjects and 334.95s 
± 45.08 SEM for controls, but no trial effect.  The time spent moving in the last hour 
(Hour11Video) had a mean for SIB subjects of 220.22s ± 30.80 SEM and control 
subjects mean of 147.17s ± 28.52 SEM; however, it yielded no significant differences 
as a function of group or trial (Fig. 2.4). 
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Figure 2.4 Average movement time for SIB and control subjects during the first 
(8pm -9pm) and last (6am -7am) hour over the baseline phase.  There was a 
significant difference between SIB and control groups for Hour 1 Time (p < .001), 
but not Hour 11 Time.  
 
SIB and control subjects did not differ on the length of the longest period of 
inactivity TBVids (SIB Subjects: 2467.17s ± 337.99 SEM and Controls: 2856.67s ± 
312.92 SEM), nor on the start time of the longest period of inactivity. TBstart, 
occurred on average at 1:30 am for the SIB subjects and around midnight for the 
controls. 
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Figure 2.5 Average longest time between videos and start time of that period for 
SIB and control subjects during the baseline phase.  There were no significant 
differences between SIB and control for either measure.  
 
 
 
 
 
 
Behavior SIB Status Phase SIB x Phase 
Total Time Moving 
(TMT) 
F(1,11) = 10.12  
p < 0.01  
F(1,11) = 2.50  
p = 0.04 
 
F(1,11)= 2.24 
p = 0.06 
Videos Greater or 
Equal to 10s (≥ 
10sVids) 
F(1,11) = 12.32  
p < 0.01 
F(1,11) = 2.69 
p = 0.03 
 
F(1,11)= 2.71 
p = 0.03  
Videos Greater or 
Equal to 30s (≥ 
30sVids) 
F(1,11) =10.02  
p < 0.01 
F(1,11) = 2.08  
p = 0.08  
 
F(1,11)= 1.76 
p = 0.14 
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Videos Less Than 10s F(1,11) = 1.83  p 
= 0.20  
F(1,11) =  1.02 
p = 0.41  
F(1,11) = 1.82  
p = 0.12  
Time Moving First 
Hour (Hour 1 Time) 
F(1,11) = 18.04  
p < 0.001  
F(1,11)= 1.67 p 
= 0.16 
F(1,11)= 1.5 p 
= 0.21 
Time Moving Last 
Hour (Hour 11 Time) 
F(1,11)= 3.03 p = 
0.11 
F(1,11)= 0.89 p 
= 0.50 
F(1,11)= 1.31 
p = 0.28 
Longest Time 
Between Videos 
(TBvid) 
F(1,11)= 0.72 p = 
0.42 
F(1,11)= 0.85 p 
= 0.53 
F(1,11)= 0.39 
p = 0.86 
Start Time of Longest 
Break Between 
Videos (TBstart) 
F(1,11)= 0.72 p = 
0.42 
F(1,11)= 0.38 p 
= 0.86 
F(1,11)= 0.93 
p = 0.47 
Table 2.3 Effects of nighttime behavior measures across SIB status, phase, and SIB 
vs.  Phase.  Significant effects are in bold.  No significant effects of SIB across trial 
were found for any measure. 
 
 
2.3.4 Daily Morning Behavior Compared to Nighttime Activity Measures  
To examine the relationship between nighttime activity and behavior the 
next day, our standardized 5-min daily behavioral assessment was used (See section 
2.2.5). Data were analyzed to examine if daytime activity predicted the following 
nighttime activity, and also if nighttime activity predicted the next day’s daytime 
activity. Comparing daytime movement to the nighttime activity exhibited the night 
after showed no significant correlations.   In the first trial, significant positive 
correlations between the total number of behaviors exhibited in the morning and 
total movement time the night before (r=0.65 p=0.02, scatterplot of data see Fig. 
2.6), and Hour 11 movement time (r=0.60 p=0.03) were detected. Locomotion score 
was positively correlated with total movement time the night before (r=0.65 p=0.02, 
scatterplot of data see Fig. 2.7), ≥30s videos (r=0.63, p=0.05), and Hour 1 Video 
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(r=0.66 p=0.01) with a trend in Hour 11 Time (r=0.54 p=0.06). While there were 
many significant correlations in the first VRNA trial, unfortunately the correlations 
did not persist through all the trials when analyzed with Bonferroni correlations. 
Only for trial 1 of the preliminary trials did macaques who had higher nighttime 
activity scores continue to exhibit more activity in the morning. 
 
   
Figure 2.6 Scatterplot of the correlation between total nighttime movement (s) and 
total behaviors shown the next morning in the first trial (p=.02, r=.65) 
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Figure 2.7 Scatter Plot of the correlation between total nighttime movement (s) and 
locomotor behaviors the next morning in the first trial (p=.02, r=.65)  
 
 
 
 
2.4 Discussion 
 During the baseline study, the VRNA system proved useful in collecting 
nighttime data in noninvasively laboratory housed populations of rhesus macaques. 
The ability of the system to provide numerous measures, such as times when 
movements occurred and duration,  helped elucidate nighttime activity patterns 
between two populations, shows that it can be used in situations where other sleep 
data collections are impossible. Measures can be selected that work best with 
research needs or all can be employed, such as in this study, to create a clear picture 
about the nature of nighttime activity in the subjects.  Where the system truly 
deviated from actigraphy is that it not only provided movement data, but specific 
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behavior information as well.  This provides a clear view one may not otherwise get 
into the nighttime behaviors and sleeping positions of subjects, which in turn can 
help inform welfare and animal care practices.  
 In the baseline, sleep postures and place preference was observed in all 
subjects, and differed among individuals as a function of housing type.  Those in 
pens  exhibited a wider range of  sleep postures than those in Allentown cages; three 
subjects, all Allentown housed, only exhibited a sitting sleeping behavior.  This is 
likely due to the nature of the Allentown cage: it is likely much harder for the 
subjects to lie down on the parallel steel bars and mesh floors of the Allentown 
cages than it is for pen housed subjects to lay on the grouped PVC pipes or 
hammocks. Pen subjects were more likely to sit exclusively in perches and avoid the 
bottom half of the cage; likely because most of the rhesus macaques avoid the 
shavings on the floor during the daytime. It is the nature of rhesus macaques to 
sleep in and inhabit tall tree branches, so being closer to the floor can be unnatural. 
For all but four subjects, there seemed to be no left/right cage place preference, but 
four invariably chose same side indicating no effect of camera placement or other 
factors on their sleeping place choice.  
The hypothesis tested in this study was that SIB is associated with sleep 
disruptions: the predictions that followed were that SIB subjects would be more 
active during the night and that they would also have more movement which in turn 
would be correlated with more total behaviors in the morning. The first prediction 
was confirmed; SIB subjects showed increased nighttime activity on a variety of 
  
33 
 
measures including TMT, 10s Videos, 30s Videos, and Hour 1 Time.  This suggests 
sleep disruption is likely a characteristic of SIB subjects.  Differences in TMT and 
Hour 1 Time, but not in Hour 11 Time, suggest SIB subjects not only move more 
during the nighttime period, but they also may take longer to settle down. ≥10s 
videos and ≥30s videos were different between SIB and control subjects, SIB 
subjects created four times as many 30s videos as controls, however there was no 
difference in the <10s video measure. This likely shows that the <10s movements 
are smaller movements common to all sleeping behaviors and may not even indicate 
the subject is awake. However, ≥10s and ≥30s videos are larger movements, 
locomotion or extensive limb movements that may indicate the subject is in fact 
awake showing some  degree of restlessness that largely differs between SIB and 
control subjects. The lack of difference between groups for the longest time between 
video creation and the start time of the longest time between video creations those 
measures may be due to too much variability in the data. The means for the separate 
groups are considerably far apart, about an hour and a half apart for TBVids, 
however too much variability may have contributed to the lack of significance here.  
These findings suggest that there was a difference between the nighttime activity of 
SIB subjects as compared to non-SIB subjects, which is consistent with previous 
evidence in both humans and rhesus macaques (Davenport et al. 2008, Polk & Liss 
2007, Symons et al. 2000, Brylewski et al. 1999).  
 The second prediction was confirmed only in the first nighttime period trial 
but not in subsequent trials. Thus, reduced sleep in the SIB monkeys did not affect 
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their daytime activity as measured in our 5-minute behavioral assessments. The 5 
min samples are typically used to establish base rates of behavior for subjects over 
time, so it is likely that a single 5 min sample may not represent a true range of 
morning behavior.  The limited period of 5 minutes made it difficult to correlate the 
behavioral assessments with a nighttime of movement.  A daytime movement 
measure over a longer period of time with a collection method more similar to 
VRNA may have produced more significant correlations. Also, for the locomotor 
movement measure, the behavioral scores could have been very low, or many 
monkeys may have not have displayed the behavior analyzed, creating many scores 
of 0 and skewing the data in a way that could not have reached significance. 
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CHAPTER 3 
PROBIOTIC STUDY 
 
3.1 Introduction 
The second aim of this thesis was to determine if probiotics, administered 
over a period of time where they would likely colonize the gut, had any effect on the 
nighttime movement of SIB and control subjects. Probiotic supplementation in 
humans and rodents has resulted in increased sleep times, increased melatonin 
levels, and reduced HPA axis activity (Jackson et al. 2015, Wong et al. 2014, 
Crumeyrolle-Arias et al. 2014, and Sudo et al. 2004).   
Through oral supplementation Bifidobacterium infantis 35624, the probiotic 
strain used in this thesis, has been shown to colonize the gastrointestinal system 
and have subsequent effects on health (Charbonneau et al. 2013).  Bifidobacterium 
infantis 35624 has been described as a psychobiotic, a probiotic that has positive 
effects on the brain and behavior: it may have improved depression symptoms, 
restored noradrenaline in the brain, and improved stress responses (Dinan et al. 
2013, Desbonnet et al. 2010, Crumeyrolle-Arias et al. 2014, and Sudo et al. 2004).  
SIB subjects have been shown to have a characteristic dysregulation of the HPA axis; 
Bifidobacterium infantis 35624 was chosen for use in this thesis because of the 
possibility that it may have had a regulatory effect on the HPA axis in that it has 
been shown to normalize HPA axis responses (Dinan et al. 2013, Lutgendorff et al. 
2008, Crumeyrolle-Arias et al. 2014, Sudo et al. 2004). Not only have probiotics 
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improved the HPA axis response, they may have also improved sleep quality, as seen 
in one preliminary study in humans (Jackson et al. 2015).  
The hypothesis for the probiotic study was that probiotic treatment would 
improve nighttime activity measures.   Predictions based on this hypothesis were 
that the probiotic, Bifidobacterium infantis 35624, would colonize and modify the 
microbiome of rhesus macaques.   If modification of the microbiome occurred, our 
prediction was that the nighttime activity measures of SIB subjects would more 
closely resemble that of controls and, over all the subjects, the movement in a 
nighttime period would have decreased: effectively improving sleep quality.   
 
3.2 Methods 
The subjects, equipment (VRNA), procedure, daily behavior scoring, and data 
collection for the probiotic study were the same as the baseline study (See part 2.2).  
The same measures were also analyzed as in the baseline study: TMT, Hour1Video, 
Hour11Video, <10s Vids, ≥10sVids, ≥30sVids, TBvid, and TBstart.  The data were 
expressed in seconds when appropriate with video durations rounded to the 
nearest hundredth second.   Daytime behavior was also considered; it was collected 
and organized using the same methods as the baseline study. Total morning 
behaviors and locomotor behaviors from the morning after night time recording 
were compiled for comparison to nighttime activity data. 
 
3.2.1 Nighttime Recording Schedule  
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As opposed to the baseline study, the ISPYCONNECT continued recording 
even after the lights went on in the morning until the equipment was removed from 
the rooms between 8-8:30 am either by M. Novak or by animal care staff.   The light 
cycle (8pm-7am) was the same.  Nighttime activity measures were considered for 
the entire lights-off period, just as in the baseline study. Trials were considered an 
entire 11-hour nighttime period (8pm-7am). The vehicle phase yielded four trials 
per each subject, and eight trials per each subject were collected during the 
probiotic phase.  
 
3.2.2 Probiotic Administration 
Probiotics were administered after the three month baseline study using a 
cross-over design. The author was blind to the probiotic conditions throughout the 
study.  The subjects on the probiotic treatment were administered one 4mg capsule, 
containing between 1 billion (at time of manufacture) and 10 million (at expiration 
date) live bacteria, of ALIGN probiotic (Bifidobacterium infantis 35624) per day 
before morning feeding. The powder from the capsule was placed into a softened 
starburst and allowed to harden. Those not on the treatment received vehicle, a 
softened and then hardened Starburst without the powder. Half the subjects were 
on treatment for four months, followed by vehicle for four months and the other half 
received vehicle for four months and treatment the following four months (See 
Figure 3.1).  Subjects were divided into two groups by laboratory suite, Group A and 
Group B. Table 3.1 shows the distribution across suites, sex, and SIB status. The 
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author was blind to the conditions under which the probiotics were administered 
until probiotic treatment for both groups ended.    
 
Figure 3.1 Probiotic study design. Each phase was four months long. The probiotic 
study was in total eight months long after both group A and group B received 
probiotics and vehicle.   
 
Group Total 
Subjects 
SIB 
Subjects 
Group A 5 4 
Group B 8 2 
Table 3.1 Distribution of sex and SIB status between treatment groups 
 
 
 
3.2.3 Data Analysis 
Nighttime activity with a factor of SIB status was analyzed using ANOVAs 
with treatment phase (baseline, vehicle and probiotic) as a within subject variable. 
The following variables were analyzed, as in the baseline study: TMT, <10s Vids, 
≥10sVids, ≥30sVids, Hour1Video, Hour 11 Video, TBvid, and TBstart. To test for 
order effects, group A was compared to Group B for the same measures also using 
ANOVAs.  
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Data analysis for the daytime behavior and nighttime activity correlations 
between the baseline study and the probiotic study was similar to experiment 1. . 
Daytime behavior was compared to nighttime activity using Pearson correlations 
with a Bonferroni correction. Morning behaviors were grouped into locomotor 
behaviors (locomotion and movement stereotypies) and total number of behaviors 
a subject displayed in a sampling period.  
 
3.3 Results 
3.3.1 Description of Sleep Patterns 
Sleep postures and sleeping place preference in the probiotic study were 
similar to those seen in the baseline. The same three sleep postures were observed 
during this study: sitting upright, lateral recumbency, or prone, but not supine.  As 
noted in Table 3.2, three subjects showed an additional sleep posture when vehicle 
and probiotic phases were added (denoted as +Y; See Table 3.3).  
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Subject Sitting Lateral 
Recumbency 
Lateral 
Recumbency 
and Prone 
Prone 
V38 Y Y N N 
V42 Y Y N N 
N02 Y +Y N N 
V43 Y Y Y Y 
V27 Y Y +Y +Y 
P58 Y Y Y Y 
RQ789 Y Y N N 
RQ705 Y N N N 
ZA63 Y Y Y Y 
ZA54 Y Y Y Y 
I18 Y Y N N 
ZA02 Y +Y N N 
N01 Y Y Y Y 
Total 
Males 
10 9 6 6 
Table 3.2   Sleeping postures observed in all phases, including baseline study, by 
subject and sex. Bold values indicate sleeping positions not seen in the baseline 
study. 
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Cage Style Right 
Side 
Left 
Side 
Hammock 
(if 
available; 
4 subjects) 
Exclusively 
perches 
Bottom Half 
of Cage 
Pen 6 6 2 4 0 
Allentown 6 6 N/A 3 1 
All 
Subjects 
12 12 2 7 1 
 Table 3.3   Sleeping place preference in all phases, including baseline study, of 
subjects based on subject and cage type.  No differences were seen between baseline 
place preference and that in the vehicle and probiotic phases. 
 
3.3.2 Nighttime Activity Differences between SIB and Control Subjects 
Increased nighttime activity in SIB monkeys persisted through all phases 
(Baseline, Vehicle, and Probiotic) in almost every measure. Order effects, as 
observed by differences in the two groups that received vehicle and probiotics at 
different times, were examined by comparing nighttime activity scores between 
Group A and Group B. For all measures, no order effects were observed. Additionally 
evaluated were nighttime activity measures between the first four and the last four 
probiotic trials: no significant differences were found for any measure.  The graphs 
for each measure are provided below and the statistical data are provided in Table 
3.5.  
 
SIB subjects continued to show significant sleep disruption as measured by 
TMT compared to controls (See Figure 3.2; F (1, 11) =9.88 p=0.01). However, there 
was no effect of phase or an interaction of SIB status by phase.   
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Figure 3.2 Average overall nighttime movement time for SIB and control subjects 
for the baseline (PRE), vehicle (VEH), probiotic (PRO) phases.   
 
 
 
SIB and control subjects remained consistently different for Hour 1 Time, 
indicating no effect of probiotics on time moving during the settling down hour (F (1, 
11) = 17.45 p< .01).  However, there was an overall effect of phase in which activity 
declined significantly across phase (see Figure 3.3; means in Table 3.4). There was 
no interaction between SIB status and phase for Hour 1 Time. 
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 Figure 3.3 Average times spent moving in the first hour for SIB and control 
subjects over the baseline (PRE), vehicle (VEH), probiotic (PRO) phases.   
 
 
 Although there was no significant effect of SIB in the baseline study for Hour 
11 Time, the amount of movement in the last hour, there was an overall effect with 
SIB subjects having more movement in the awakening hour (Hour 11 Time)  (Figure 
3.4; F (1, 11) = 4.88 p=0.05). There was no overall phase effect, but the analysis 
revealed a significant   interaction between SIB status and phase which was 
significantly quadratic (F (1, 11) = 6.54 p=0.03). The differences between SIB and 
control subjects were greatest during the vehicle phase. 
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Figure 3.4 Time spent moving in the last hour (6am-7am) for SIB and control 
subjects over the baseline (PRE), vehicle (VEH), probiotic (PRO) phases.  
 
 
Just as in the baseline study <10s, the measure of shortest movements a 
subject could make, there were no significant differences between SIB and control 
subjects or as a function of phase (Overall: F (1, 11) =1.51 p=0.24). The longer videos, 
≥10s Videos and ≥30s Videos, were measures that SIB subjects were significantly 
higher than controls on for the baseline study.  The ≥10s Videos measure remained 
significantly higher in SIB subjects compared to controls (Figure 3.5; F (1, 11) = 3.36 
p=0.05). A significant phase effect revealed a decrease in all subjects from baseline 
to vehicle (F (1, 11) = 6.44 p=0.03).  
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Figure 3.5 Average numbers of videos created over 10s long during a nighttime 
period for SIB and control subjects over the baseline (PRE), vehicle (VEH), probiotic 
(PRO) phases.  
 
 
 
The >30s videos measure remained higher among SIB subjects across all 
phases as well (Figure 3.6; F (1, 11) = 11.82 p=0.01).  This measure was over four 
times higher in SIB subjects, 12.56 average videos vs. 2.25 for controls, indicating a 
large difference in the longest videos a subject could create where they were most 
likely awake. ≥30s did not show any phase effects.  
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Figure 3.6 Average number of videos created over 30s for SIB and control subjects 
over the baseline (PRE), vehicle (VEH), probiotic (PRO) phases. 
 
 
There were no significant effects for TB vids, the longest time between video 
creation (see Fig 3.7) or TB start, the start time of the TB vids measure (See Fig. 3.8).  
 
Figure 3.7 Average longest times between video 
creation for SIB and control subjects for the baseline 
(PRE), vehicle (VEH), probiotic (PRO) phases.  
Figure 3.8 Start of longest time between video 
creation for SIB and control subjects for the 
baseline (PRE), vehicle (VEH), probiotic (PRO) 
phases.  
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Table 3.4 Effects of nighttime behavior measures over all phases including baseline 
study.  Significant effects are in bold.   
 
3.3.3 Daily Morning Behavior Compared to Nighttime Activity Measures  
 As in the baseline data were analyzed to examine if daytime activity 
predicted the following nighttime activity, or if nighttime activity predicted the 
following morning’s daytime activity. There were no correlations between any 
daytime behaviors and nighttime measures collected. 
 
Measure OVERALL SIB 
status 
OVERALL phase OVERALL SIB x Phase 
TMT  F(1,11)=9.88 
p=0.01 
F(2,22)=1.89 p=0.17 F(2,22)=1.19 p=0.32 
Hour 1 
Time 
 F(1,11)=17.45 
p<0.01 
F(2,22)=14.24  p<0.01 
(linear F(1,11)=17.01 
p<0.01) 
F(2,22)=0.60 p=0.56 
Hour 11 
Time 
F(1,11)=4.88 
p=0.05 
F(2,22)=1.06 p=0.36 F(2,22)=3.65 p=0.04 
(quadratic p=0.03 
F(1,11)=6.54) 
<10s 
Videos 
F(1,11)=1.51 
p=0.24 
F(2,22)=0.59 p=0.56 F(2,22)=0.59 p=0.56 
≥10s 
Videos 
F(1,11)=12.00 
p=0.01 
F(2,22)=3.36 p=0.05 (linear 
F=6.44 p=0.03) 
 
F(2,22)=0.25 p=0.78 
≥30s 
Videos 
F(1,11)=11.82 
p=0.01 
F(2,22)=0.92  p=0.41 F(2,22)=1.85 p=0.18 
TB Videos  F(1,11)=3.34 
p=0.09 
F(2,22)=0.97 p=0.40 F(2,22)=1.01 p=0.38 
TB Start F(1,11)=2.42 
p=0.15 
F(2,22)=1.13 p=0.34 F(2,22)=0.38 p=0.69 
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3.4 Discussion 
The hypothesis of this study, that Bifidobacterium infantis 35624 would 
normalize gut function and neurotransmitter activity, and nighttime activity would 
subsequently be reduced, was not confirmed. Differences between SIB and control 
subjects with SIB subjects having much higher nighttime activity measures, 
persisted throughout all phases of the probiotic treatment.  Although 
Bifidobacterium infantis 35624 supplementation did not change nighttime activity of 
the subjects, it did have efficacy on daytime behavior through a reduction of SIB 
seen during behavioral data collection (data not shown).  This is evidence that 
Bifidobacterium infantis 35624 did in fact produce a change; however it was not 
related to the measures examined in this thesis. This indicates increased nighttime 
activity is likely a persistent characteristic of the SIB pathology.  
There are several issues to consider in the failure of probiotic treatment to 
alter sleep. First, the treatment may not have been sufficiently long enough to effect 
change. These subjects may have a large disruption of their sleep cycle, and four 
months of Bifidobacterium infantis 35624 supplementation may not have been long 
enough to effect an observable change. Second, while Bifidobacterium infantis 35624 
was carefully chosen due to its reported effects on the HPA axis, other probiotic 
strains could be chosen that may have a larger effect on nighttime activity. Third, 
extent of sleep disruption may be possibly greater in these SIB subjects than those 
at other facilities. It is important to note that the sleep disruption in the SIB subjects 
at this facility, while difficult to compare, was greater than that in those subjects 
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reported in the 2008 Davenport et al. study. The sleep disruption in our subjects 
may have been aggravated during recent construction that lasted over two years in 
close proximity to the facility where the subjects lived.  Construction has been 
shown to have a negative effect on rhesus macaques, and may have had a larger 
effect on SIB subjects, subsequently increasing nighttime activity. In this case, a 
more effective treatment for reducing nighttime activity may be a sleep aid such as 
melatonin, which has been shown to promote sleep in rhesus macaques (Zhdanova 
et al. 2002).  
Nighttime activity did not correlate with activity during the next day nor did 
daytime activity correlate with activity that following night. Although it is possible 
that these are unrelated, another possibility has to do with that two different 
scoring systems were not easily correlated. The VRNA method provided an entire 
nighttime of movement which was compared to a five-minute behavioral sample; 
these two methods were scored differently and subsequently were difficult to 
compare. Also, a five minute sample does not provide as comprehensive a picture of 
the subject’s behavior as a measure that takes into account the entire nighttime 
period. A comparison between a daytime movement measure that took into account 
a longer period of time and the measures VRNA provided may have been more 
successful 
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CHAPTER 4 
GENERAL DISCUSSION 
This thesis established the VRNA system as a new method to naturalistically 
measure nighttime movement in rhesus macaques, an improvement on the methods 
used previously in the Davenport et al. 2008 study.  In contrast to actigraphy, the 
VRNA system provided movement data, sleeping positions, and most importantly 
yielded videos that could be scored for behavior. VRNA will never be as reliable a 
measure for assessing sleep as PSG but the advantage it has over other methods, 
especially in animal models, is its naturalistic methodology: no surgeries or 
disruption of the subject is required and it is quick and easy to implement.  
The system can also be modified to suit facilities with differing capabilities. 
For facilities with WIFI, the current cameras can be replaced with wireless IP 
cameras in order to negate the use of a directly connected laptop and to improve 
camera range.  To better compare nighttime activity with daytime activity, the VRNA 
system could be used with regular webcams during the day.  The computer program 
could also be used with other experimental procedures to assess movements during 
the procedures (e.g., cognitive testing, human intruder test).   
Overall, no correlation between daytime and nighttime data was apparent in 
the probiotic study and only the first trial of a total of six trials during the baseline 
study revealed correlations between nighttime activity and locomotor and total 
behaviors the next morning. Correlations only present in the first trial show that the 
novelty of the recording system in the colony rooms influenced behavior in a way 
  
51 
 
that is not clear. The lack of correlations after the first exposure may have been due 
to the behavioral scoring system used during the day in which two-5 min samples 
were collected. In the future, a better procedure would be to use the VRNA system 
both at night and for long periods of time during the day (excluding feeding times).  
This thesis replicated findings that previously suggested a difference in 
nighttime activity between SIB and control subjects in humans and rhesus 
macaques, possibly revealing a defining attribute of the condition (Davenport et al. 
2008, Polk & Liss 2007, Symons et al. 2000, Brylewski et al. 1999). Sleep 
disturbance has been characterized in individuals exhibiting SIB in the past, but 
often in the context of other studies (in the case of relocation stress in rhesus 
macaques, Davenport et al. 2008; or fluoxetine treatment in humans, Sovner et al. 
1993). In the rhesus monkey paper, 1 min scan samples were used to assess 
nighttime activity through the middle portion of the night which was recorded using 
a 3 point scale (sleeping posture eyes closed, awake and still, awake and active). 
This procedure was limited for a number of reasons, these included that 1) only a 
portion of the night was scored, 2) measures such as hour 1 and hour 11 were not 
recorded, 3) the scan sampling procedure captured only a small amount of data: 
only about 16% of the recorded nighttime period was scored, and 4) using scale 
values requiring judgments from scorers rather than having the program 
automatically calculate standard measures such as total movement time could have 
resulted in human error.  Thus, prior to this thesis, most SIB sleep disturbance 
studies relied on subjective assessments or arduous videotape scoring methods that 
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missed much of the nighttime period through scan sampling every few minutes and 
not having enough videotape capacity to capture the entire time when the lights 
were off.   
Overall, the persistent differences between SIB and control groups indicating 
increased nighttime activity in SIB subjects through the baseline study and the 
probiotic study indicates that sleep disruption seems to be a characteristic of 
individuals displaying the SIB phenotype. SIB and increased nighttime activity seem 
to be inherently linked, however, it is unknown if increased nighttime activity 
affects SIB subjects negatively or if SIB subjects require less sleep. Also, it is unclear 
which of the conditions appeared first. Sleep disturbance may result in elevated SIB, 
or the SIB pathology could result in sleep disruption. Future studies could examine 
that if sleep was improved through a sleep aid if SIB pathology would be improved 
as well. 
Past studies have also not detailed what kind of sleep disruption the SIB 
individuals experience, only that they exhibit more nighttime movement than 
others. Only one case study of a woman exhibiting the SIB pathology detailed her 
sleep disturbance as including difficulty falling asleep, awakening in the middle of 
the night, and early morning awakening (Sovner et al. 1993). Sleep disturbance can 
take a few different forms: sleep-onset insomnia, sleep-maintenance insomnia, and 
early-awakening insomnia (American Psychiatric Association 2000). Across both 
studies there were overall higher measures between SIB and control subjects 
between most measures examined that may indicate issues in all categories of 
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insomnia.  A higher effect in first-hour movement time suggested sleep-onset 
insomnia. The SIB subjects did have longer total movement time, overall longer 
videos, and shorter length of the longest time between videos, which suggests a 
sleep maintenance issue. Last hour movement time differed between SIB subjects 
and controls, indicating early-awakening insomnia. While SIB subjects do exhibit 
increased nighttime activity that implies some sleep disruption and insomnia issues, 
it is hard to uncover what type of insomnia the subjects experience without more in-
depth sleep studies.  
Bifidobacterium infantis 35624 was used in this thesis in order to normalize 
high nighttime activity measures seen in rhesus macaques with self-injurious 
behavior and also improve nighttime activity scores overall.  Bifidobacterium 
infantis 35624 was the probiotic chosen specially because of its effects on stress and 
the HPA axis: normalizing HPA axis activity, modulating the effects of anxiety, 
improving symptoms of depression (Desbonnet et al. 2008, Lomasney et al. 2013, 
Groeger et al. 2013, Mckernan et al. 2010, Konieczna et al. 2012). Bifidobacterium 
infantis 35624 has also been shown to decrease pain, affect immunoregulation, and 
decrease inflammation; effects that may have also contributed to decreasing 
nighttime activity along with the desired HPA axis effects that it was selected for. 
SIB subjects have a dysregulation of the HPA axis, and normalization of the HPA axis 
may possibly improve sleep disruption due a link between cortisol and melatonin 
(Davenport et al. 2008, Tiefenbacher et al. 2004). Despite these previous findings, 
no effect of probiotics on nighttime activity was observed; possibly due to that fact 
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that extent of sleep disruption may be possibly greater in these SIB subjects than 
those at other facilities, and therefore the treatment may not have been sufficient or 
administered long enough to effect change. Therefore, other treatments that 
specifically target sleep may be more appropriate for improving the increased 
nighttime activity seen in the SIB subjects in this thesis. These treatments could 
include a supplement of melatonin, shown to improve sleep in rhesus macaques 
(Zhdanova et al. 2002). In the past, probiotics have improved melatonin levels in 
addition to sleep measures themselves; this could be a factor in probiotics possibly 
improving sleep disruption in other populations with less severe sleep disruption 
(Jackson et al. 2015, Wong et al. 2014).  
Bifidobacterium infantis 35624 did not seem to have a noticeable effect on 
nighttime activity measures.  There were no meaningful interactions between SIB 
and trial or any indication that nighttime activity scores were improved overall. The 
effect of Bifidobacterium infantis 35624 was inconclusive at best, and further 
research into the topic is necessary.  
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APPENDIX 
TABLE OF PROBIOTIC STUDY MEANS 
 
Table 1. SIB and control means for all measures considered for all phases.  
Measure VEH SIB 
Mean 
VEH 
Control 
Mean 
PRO SIB 
Mean 
PRO 
Control 
Mean  
OVERALL 
SIB Mean 
OVERALL 
Control 
Mean 
TMT 1800.54s 
± 303.32 
SEM 
616.79s ± 
280.82 
SEM 
1510.02s 
± 223.45 
SEM 
649.55s ± 
206.87SEM 
1687.54s ± 
245.34 
SEM 
703.80s ± 
227.14 SEM 
Hour 1 
Time 
431.75s ± 
58.08 SEM 
134.39s ± 
53.77 
SEM 
430.77s ± 
62.79 SEM 
212.64s ± 
58.13 SEM 
493.08s ± 
56.52 SEM 
227.33s 
±  52.33 SEM 
Hour 11 
Time 
290.54s ± 
48.99 SEM 
111.46s ± 
45.36 
SEM 
213.25s ± 
43.06 SEM 
126.61s ± 
39.87 SEM 
241.34s ± 
40.95 SEM 
128.41s ± 
37.92 SEM 
<10s 
Videos 
154.71 
videos ± 
29.62 SEM 
98.54 
videos ± 
27.09 
SEM 
140.44 
videos ± 
30.59 SEM 
105.57 
videos ± 
28.32 SEM 
149.39 
videos ± 
26.66 SEM 
106.68 
videos ± 
24.68 SEM 
≥10s 
Videos 
90.08 
videos ± 
13.87 SEM 
35.43 
videos ± 
12.84 
SEM 
80.65 
videos ± 
10.23 SEM 
33.55 
videos ± 
9.47 SEM 
88.97 
videos ± 
11.56 SEM 
38.21 videos 
± 10.70 SEM 
≥30s 
Videos 
15.54 
videos ± 
3.36 SEM 
1.54 
videos ± 
3.11 SEM 
10.27 
videos ± 
2.25 SEM 
2.25 
videos ± 
2.08 SEM 
12.56 
videos ± 
2.56 SEM 
2.25 videos 
± 2.37 SEM 
TB Time 2316.50 s 
± 674.57 
SEM 
3478.36s 
± 624.53 
SEM 
2479.81s 
± 425.16 
SEM 
3859.79 s 
± 393.62 
SEM 
2421.76s ± 
479.24 
SEM 
3398.27s ± 
443.69 SEM 
TB Start 16551.79s 
± 2782.64 
SEM 
14359.11s 
± 2576.23 
SEM 
24278.71s 
± 5194.31 
SEM 
16273.14s 
± 4808.99 
SEM 
19733.31s 
± 3438.66 
SEM 
14978.43s ± 
3183.58 
SEM 
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